Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Posted On Wednesday, March 05, 2025
EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments
Posted On Wednesday, March 05, 2025
Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors
Posted On Wednesday, March 05, 2025
Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain
Posted On Wednesday, March 05, 2025
Supernus to Participate in Two Upcoming Investor Conferences
Posted On Tuesday, March 04, 2025
IO Biotech Reports 2024 Business Highlights
Posted On Tuesday, March 04, 2025
Lexicon Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
Posted On Tuesday, March 04, 2025
Arvinas to Participate in Upcoming Investor Conferences
Posted On Tuesday, March 04, 2025
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
Posted On Tuesday, March 04, 2025
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
Posted On Tuesday, March 04, 2025
Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida
Posted On Tuesday, March 04, 2025
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Posted On Tuesday, March 04, 2025
NanoNewron Appoints Industry Veteran Marco Taglietti, M.D., as Chief Executive Officer to Lead the Company and the Development of Their Promising Alzheimer’s Compound
Posted On Tuesday, March 04, 2025
Plus Therapeutics Secures Private Placement of Approximately $15 Million in Gross Proceeds
Posted On Tuesday, March 04, 2025
NKGen Biotech, Inc. to Transition from the Nasdaq Global Market to OTC Markets; Reverse Stock Split will not be Implemented
Posted On Tuesday, March 04, 2025
Iridia Makes History: First Cryptocurrency and Molecular Off-World Data Archive Successfully Lands on the Moon
Posted On Tuesday, March 04, 2025
Better Choice Company Appoints Renowned Expert in Rare and Undiagnosed Diseases, Dr. Paldeep S. Atwal, as its United States Special Healthcare Advisor
Posted On Tuesday, March 04, 2025
Optime Care Partners with Eton Pharmaceuticals as a Specialty Pharmacy Provider for GALZIN®
Posted On Tuesday, March 04, 2025
Irazú Oncology Secures Bridge Funding, Expands Leadership Team and Facilities
Posted On Tuesday, March 04, 2025
LinkGevity Awarded Innovate UK Smart Grant for Anti-Necrotic™ Research to Prevent Kidney Deterioration
Posted On Tuesday, March 04, 2025
FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results
Posted On Monday, March 03, 2025
ARS Pharmaceuticals Announces Conference Call and Webcast for its Fourth Quarter and Full Year 2024 Financial Results and Participation at Upcoming Conferences
Posted On Monday, March 03, 2025
23andMe Special Committee Rejects Acquisition Proposal From CEO Anne Wojcicki
Posted On Monday, March 03, 2025
ANI Pharmaceuticals Announces FDA Approval of New Purified Cortrophin Gel® Prefilled Syringe
Posted On Monday, March 03, 2025
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
Posted On Monday, March 03, 2025

Print